West Nile fever in the background of the COVID-19 pandemic
Authors:
E. Křížová 1; H. Lejdarová 1,2; I. Rudolf 3
Authors‘ workplace:
Transfuzní a tkáňové oddělení, FN Brno
1; LF MU, Brno
2; Ústav biologie obratlovců AV ČR Brno
3
Published in:
Transfuze Hematol. dnes,27, 2021, No. 4, p. 316-321.
Category:
Review/Educational Papers
doi:
https://doi.org/10.48095/cctahd2021316
Overview
Due to climate change, tropical pathogens are spreading throughout Europe, posing a risk to the safety of haemotherapy in the Czech Republic. The first occurrence of the West Nile virus (WNV) in the Czech Republic was documented as early as 1985 and it has been demonstrated that WNV has been circulating in the Czech Republic for a long time. Transmission of WNV infection by blood transfusion has been known known since 2002. In 2018, five locally acquired (autochthonous) WNV human infections were confirmed in the South Moravian Region, and the transfusion service facility was faced with the question of how to adequately ensure transfusion product in the region in accordance with mandatory legislation. The readiness of Czech transfusion services to deal with similar situations must be ensured every WNV season. This is not possible without close cooperation with infectologists and epidemiologists. This article summarizes basic data on the occurrence of WNV in the Czech Republic and on the procedures to ensure safety of haemotherapy in relation to WNV.
Keywords:
haemotherapy – Blood donors – West Nile virus – WNV
Sources
1. Paz S, Semenza JC. Environmental drivers of West Nile fever epidemiology in Europe and West Asia – A review. Int J Environ Res Public Health. 2019; 10: 3543–3562.
2. Semenza JC, Suk JE. Vector-borne diseases and climate change: a European perspective. FEMS Microbiol Lett. 2018; 365.
3. Semenza JC, Tran A, Espinosa L, Sudre B, Domanovic D, Paz S. Climate change projections of West Nile virus infections in Europe: implications for blood safety practices. Environ Health. 2016; 15 (Suppl 1): 28.
4. Semenza JC. Climate change and human health. Int J Environ Res Public Health. 2014; 11: 7347–7353.
5. Arbeitskreis B. West Nile virus. Transfus Med Hemother. 2013; 40: 265–284.
6. Zeller HG, Schuffenecker I. West Nile virus: an overview of the spread in Europe and the Mediterranean Basin in contrast to its spread in the Americans. Eur J Clin Microbiol Infect Dis. 2004; 23: 47–156.
7. Rudolf I, Blažejová H, Šebesta O, et al. West Nile virus (linie 2) v komárech na jižní Moravě – očekávání prvních autochtonních lidských případů. Epodemiol Mikrobiol Imunol. 2018; 67 (1): 44–46.
8. Vlčková J, Rupeš V, Horáková D, Kollárová H, Holý O. Rizika šíření viru západonilské horečky v České republice. Epodemiol Mikrobiol Imunol. 2015; 64 (2): 80–86.
9. Pauli G, Bauerfeind U, Blumel J, et al. West Nile virus. Transfus Med Hemother. 2013; 40: 265–284.
10. Pisani G, Cristiano K, Pepella S, Liumbruno GM. West Nile virus in Europe and safety of blood transfusion. Transfus Med Hemother. 2016; 43: 158–167.
11. Grossner CM, Marrama L, Carson M, et al. West Nile Virus surveillance in Europe: moving towards an integrated animal-human-vector approach. Euro Surveill. 2017; 22 (18): 30526.
12. Rudolf I, Betášová L, Blažejová H, et al. West Nile virus in owervintering mosquitoes, central Europa. Parasites Vectors. 2017; 10: 452.
13. Rudolf I, Bakonyi T, Šebesta O, et al. West Nile virus lineage 2 isolated from Culex modestus mosquitoes in the Czech Republic, 2013: expansion of the European WNV endemic area to the North? Euro Surveill. 2014; 19 (31): 20867.
14. Pauli G, Bauerfeind U, Blumel J, et al. West Nile virus. Transfus Med Hemother. 2013; 40: 265–284.
15. Hubálek Z, Juřicová Z, Halouzka J, Pellantová J, Hudec K. Arboviruses associated with birds in southern Moravia, Czechoslovakia. Acta Sci Natur Brno. 1989; 23 (7): 1–50.
16. Juřicová Z. Antibodies to arboviruses in game animals in Moravia, Czechland. Vet Med. 1992; 37: 633–636.
17. Juřicová Z, Hubálek Z, Halouzka J, Macháček P. Virological examination of cormorants for arboviruses. Vet Med. 1993; 38: 375–379.
18. Hubálek Z, Kříž B, Halouzka J. Serologic survey of humans for Flavivirus West Nile in South Moravia (Czech Republic). Cent Eur J Public Health. 2011; 19 (3): 13 –133.
19. Hubálek Z, Halouzka J, Juřicová Z, Šebesta O. First isolation of mosquito-borne West Nile virus in the Czech Republic. Acta Virol. 1998; 42: 119–120.
20. Hubálek Z, Halouzka J, Juřicová Z. West Nile fever in Czechland. Emerg Infect Dis. 1999; 5: 594–595.
21. Hubálek Z, Halouzka J, Juřicová Z, Příkazský Z, Žáková J, Šebesta O. Surveillance of mosquito-borne viruses in Břeclav after the flood of 1997. Epidemiol Mikrobiol Immunol. 1999; 48 (3): 91–96.
22. Hubálek Z, Savage HM, Halouzka J, Juřicová Z, Sanogo YO, Lusk S. West Nile virus investigations in South Moravia, Czechland. Viral Immunol. 2000; 13 (4): 427–433.
23. Kazdová K, Hubálek Z. Vyšetření komárů na přítomnost arbovirů na jižní Moravě v letech 2006 – 2008. Epidemiol Mikrobiol Imunol. 2010; 59 (3): 107–111.
24. Hubálek Z, Rudolf I, Bakonyi T, et al. Mosquito (Diptera: Culicidae) surveillance for arboviruses in an area endemic for West Nile (lineage Rabensburg) and Ťahyňa viruses in central Europe. J Med Entomol. 2010; 47: 466–472.
25. Sedlák K, Zelená H, Křivda V, Šatrán P. Surveillance západonilské horečky u koní v České republice v letech 2011 – 2013. Epidemiol Mikrobiol Imunol. 2014; 63: 307–311.
26. Rudolf I, Rettich F, Betášová L, et al. West Nile virus (linie 2) poprvé detekován v komárech v jižních Čechách. Nová endemická hrozba? Epidemiol Mikrobiol Imunol. 2019; 68 (3): 150–153.
27. Tran A, Suder B, Paz S, et al. Environmental predictors of West Nile fever risk in Europe. Int J Health Geogr. 2014; 13: 26.
28. Ciupek R, Juráš P, Šebesta O, Rudolf I, Šikutová S, Zelená H. Západonilská horečka – autochtonní výskyt na jižní Moravě v roce 2018 z pohledu epidemiologa. Epidemiol Mikrobiol Imunol. 2019; 68 (4): 159–167.
29. ECDC. West Nile virus infection. In: Annual Epidemiological Report for 2019, Stockholm: ECDC; 2021.
30. Paeler LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003; 349: 1236–1245.
31. Biggerstaff BJ, Petersen L. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion. 2002; 42: 1019–1026.
32. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood componentns. Official Journal of the European Union. L 91/25, 2004.
33. Vyhláška o systému epidemiologické bdělosti pro vybrané infekce. Sbírka zákonů č. 473/2008. 2008; Částka 151: 8010–8043.
34. Vyhláška o stanovení bližších požadavků pro zajištění jakosti a bezpečnosti lidské krve a jejích složek (vyhláška o lidské krvi). Sbírka zákonů č. 143/2008. 2008; Částka 45: 1803–1838.
35. Metodický pokyn, kterým se stanoví postup při posuzování rizika nákazy virem západonilské horečky a postup ke snížení rizika přenosu tohoto viru transfuzí. Věstník MZ číslo 5/2019.
36. Stručná zpráva o výskytu západonilské horečky u lidí v roce 2018 v České republice a v Evropě. Dostupné z: http: //www.szu.cz/uploads/Epidemiologie/WNF/Strucna_zprava_o_vyskytu_zapadonilske_horecky_u_lidi_2018.pdf.
37. ECDC. West Nile virus infection. In: ECDC. Annual Epidemiological Report for 2018, Stockholm: ECDC; 2019.
38. Domanovič D, Gossner CM, Lieshout-Krikke R, et al. West Nile and Usutu virus infections and challenges to blood safety in the European Union. Emerg Infect Dis. 2019; 25 (6): 1050–1057.
39. Kolodziejek J, Jungbauer Ch, Aberle SW, et al. Integrated analysis of human-animal-vector surveillance: West Nile virus infections in Austria, 2015–2016. Emerging Microbes Infect. 2018; 7: 25.
40. Papa A, Politis C, Tsoukala A, et al. West Nile virus lineage 2 from blood donor, Greece. Emerg Infect Dis. 2012; 18 (4): 688–689.
41. Orlíková H, Špačková M, Liptáková M, Maďáková Z, Fabiánová K, Macková B. Západonilská horečka v Evropě, místní přenos v České republice – aktualizace k 5. říjnu 2018. Zprávy centra epidemiologie a mikrobiologie (SZÚ Praha) 2018; 27 (9): 222–225.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2021 Issue 4
Most read in this issue
- Hypereosinophilia
- Congenital neutropenia in children and adults
- Neuro-immune interactions in the oncogenesis of multiple myeloma and their therapeutical relevance
- West Nile fever in the background of the COVID-19 pandemic